Arkolith/Insider Trading/ATNF/Form 4/A

Jordan Blair

Chief Executive Officer, Director, 10% Owner180 Life Sciences Corp. (ATNF) · full profile →Form 4/A · filed Jun 30, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2025Grant(A)168K—$0168K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2025Grant(A)410K—$0410K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001213900-25-059794) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML